Down 25% from Oct 29 to Nov 10.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| The company | Profit up 655% to $57M |
| Latest filing | 8-K, Nov 2 |
After its last 4 reports it closed +1.7% on average, higher 3 of 4 times.
BVS is #40 of 84 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 40 |
Expected to report Tue Mar 9, before the open (in 119 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $142.4M, 3% more than a year ago; a profit of $0.08 a share, from $0.05.
“For the third quarter, worldwide revenue of $142.4 million advanced 3%, primarily driven by growth in Pain Treatments.”
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| U.s. | $125M | $134M | $123M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 2)
| Measure | Figure |
|---|---|
| Net sales | $590M to $595M |
“Adjusted EBITDA* of $28.4 million advanced 7% from $26.6 million in the prior-year period due to higher revenue and disciplined cost management, which was partially offset by increased investments to fund future growth.”
From its results filing (SEC filing · Nov 2)
Sales grew 12% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 3.9% a year over 3 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 2, 2026 | -16.2% | -16.8% | -16.2% |
| Aug 5, 2026 | -5.4% | +13.7% | +3.2% |
| May 6, 2026 | -2.6% | +2.3% | -5.1% |
Sales grew in four of the last six years, to $568M in 2025. It turned a profit in 2025 after a loss in 2024.
RSI 36.0, MACD below signal, below its 50-day, above its 200-day. Not scored.
Officers and directors with a Form 4 in the last 12 months.
In ETFs: BVS is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
“The medical device industry is highly competitive, subject to change and significantly affected by the activities of industry participants.”
BVS scores 6 today, which Breakaway calls Average. It is #40 of 84 in Medical Devices by Quality Score, with 2 of 14 chart checks firing. Down 25% from Oct 29 to Nov 10. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
BVS scores 6 today, which Breakaway calls Average (6 to 10). That is #40 of 84 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind BVS's 6.
Expected to report Tue Mar 9, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. BVS closed higher after 3 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.